A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 168
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : WTO
Long Form : World Trade Organization
No. Year Title Co-occurring Abbreviation
2022 A Global Intellectual Property Waiver is Still Needed to Address the Inequities of COVID-19 and Future Pandemic Preparedness. ---
2022 A Needle in a Haystack? Human Rights Framing at the World Trade Organization for Access to COVID-19 Vaccines. ---
2022 A novel machine learning approach to predict the export price of seafood products based on competitive information: The case of the export of Vietnamese shrimp to the US market. FAO, SHAP
2022 Access to COVID-19 Vaccines: A New Global Approach. COVID-19, IHR, IP, WHO
2022 Analyzing the Morality of Owning and Suspending Patent Rights for COVID-19 Vaccines in the Light of Catholic Social Teaching. CST
2022 Does technology innovation matter for environmental pollution? Testing the pollution halo/haven hypothesis for Asian countries. ARDL
2022 Export Expansion May Increase Adult Illness and Injury: A Quasi-Natural Experiment on China's Accession to the World Trade Organization. AE, AE
2022 From OIE standards to responsible and prudent use of antimicrobials: supporting stewardship for the use of antimicrobial agents in animals. AMR, AMU, GAP, OIE, PVS
2022 Has the Spread of African Swine Fever in the European Union Been Impacted by COVID-19 Pandemic? ASF, OIE
10  2022 Improving Access to COVID-19 Vaccines: An Analysis of TRIPS Waiver Discourse among WTO Members, Civil Society Organizations, and Pharmaceutical Industry Stakeholders. ---
11  2022 Industry influence over global alcohol policies via the World Trade Organization: a qualitative analysis of discussions on alcohol health warning labelling, 2010-19. TBT
12  2021 Are WTO Decisionmakers Regulating Technological Risks or Are Technological Risks Steering WTO Biotechnology Legal Decisions? ---
13  2021 Autonomy and international organisations. IOs, P-A, WHO
14  2021 COVID-19 Vaccine, TRIPS, and Global Health Diplomacy: India's Role at the WTO Platform. GHD, IPRs, TRIPS
15  2021 Does TRIPS (Agreement on Trade-Related Aspects of Intellectual Property Rights) prevent COVID-19 vaccines as a global public good? ACT, WHA
16  2021 Global health diplomacy at the intersection of trade and health in the COVID-19 era. COVID-19, TRIPS
17  2021 Globalization and environment: Effects of international trade on emission intensity reduction of pollutants causing global and local concerns. ---
18  2021 Globalization and working conditions in international supply chains. EPZ, ILO, SEZ
19  2021 Glossary on free trade agreements and health part 1: the shift from multilateralism and the rise of 'WTO-Plus' provisions. FTAs
20  2021 Glossary on free trade agreements and health part 2: new trade rules and new urgencies in the context of COVID-19. FTAs
21  2021 Neoliberal discourse, actor power, and the politics of nutrition policy: A qualitative analysis of informal challenges to nutrition labelling regulations at the World Trade Organization, 2007-2019. HICs, LMICs, TBT
22  2021 Role of trade openness, export diversification, and renewable electricity output in realizing carbon neutrality dream of China. ---
23  2021 The impact of preferential trade agreements on bilateral trade: A structural gravity model analysis. GVCs, MRIO, PTAs
24  2021 What You Don't Know About the Codex Can Hurt You: How Trade Policy Trumps Global Health Governance in Infant and Young Child Nutrition. CAC, CMFs, CSFUF, WHO
25  2021 What's yours is ours: waiving intellectual property protections for COVID-19 vaccines. IP
26  2020 Animal welfare in the context of World Trade Organization dispute settlement. OIE
27  2020 Building capacity for World Trade Organization dispute settlement: piloting polarity mapping for trade relations. ---
28  2020 Call for international cooperation and collaboration to effectively tackle the COVID-19 pandemic. WHO
29  2020 Changes in alcoholic beverage preference and consumption in Taiwan following accession to the World Trade Organization. aRR, CI, NAHSIT, PRR
30  2020 Changing the narrative on fisheries subsidies reform: Enabling transitions to achieve SDG 14.6 and beyond. SDG
31  2020 Disease-free zones: bilateral recognition procedure in South America. OIE
32  2020 Facilitating market access: risk assessment, equivalence and regionalisation provisions in the Agreement on the Application of Sanitary and Phytosanitary Measures. ---
33  2020 Harnessing trade and investment agreements to promote public health. FTA, GATT, ISDS
34  2020 Hollow Threats: Transnational Food and Beverage Companies' Use of International Agreements to Fight Front-of-Pack Nutrition Labeling in Mexico and Beyond. FoPNL, NAFTA, TFBCs, USMCA
35  2020 Implementation of OIE international standards: challenges and opportunities for monitoring. OIE, PVS, WAHIS
36  2020 International regulatory cooperation: contribution of the OIE and the WTO Agreement on the Application of Sanitary and Phytosanitary Measures and SPS Committee. OIE
37  2020 The impact of natural disasters on China's macroeconomy. SUR, SVAR
38  2020 The World Trade Organization Agreement on the Application of Sanitary and Phytosanitary Measures and veterinary control procedures. ---
39  2020 World Trade Organization disputes related to animal diseases. OIE
40  2019 Brexit and Animal Welfare Impact Assessment: Analysis of the Opportunities Brexit Presents for Animal Protection in the UK, EU, and Internationally. CAP, EU, PETS, UK
41  2019 Development of model web-server for crop variety identification using throughput SNP genotyping data. ABS, DUS, IPR, PBR
42  2019 International Trade and Health Care in Brazil: An Unpredicted Tale Threatening Health Care Entitlement? GATS
43  2019 Linkages between Trade, CO2 Emissions and Healthcare Spending in China. ---
44  2019 Trade of aquatic animals and aquatic animal products: the use of OIE international standards for devising sanitary measures. OIE
45  2019 World Trade Organization membership and changes in noncommunicable disease risk factors: a comparative interrupted time-series analysis, 1980-2013. ---
46  2018 'Bioexit': navigating the policy and regulatory pathways for the biotechnology industry in a post-Brexit landscape. EEA, EU
47  2018 Global governance and the broader determinants of health: A comparative case study of UNDP's and WTO's engagement with global health. UNDP
48  2018 Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001-2016. ---
49  2018 Trade challenges at the World Trade Organization to national noncommunicable disease prevention policies: A thematic document analysis of trade and health policy space. NCDs
50  2017 An International Model for Antibiotics Regulation. OIE
51  2017 Smoke screen? The globalization of production, transnational lobbying and the international political economy of plain tobacco packaging. MNEs
52  2017 Thinking Out of the Box: A Green and Social Climate Fund Comment on "Politics, Power, Poverty and Global Health: Systems and Frames". ---
53  2016 Implementing Intellectual Property of Pharmaceuticals in Middle-Income Countries: A Case Study of Patent Regulation in Brazil. IP
54  2016 Rhetoric and the law, or the law of rhetoric: How countries oppose novel tobacco control measures at the World Trade Organization. ---
55  2016 ROLE OF THE INTERNATIONAL ORGANIZATIONS IN PREVENTING THE COUNTERFEIT MEDICINES ENTRY INTO THE WORLD MARKETS. UN, UNODC, WCO, WHO, WIPO
56  2016 Support for international trade law: The US and the EU compared. PTAs
57  2016 The Trans-Pacific Partnership and pharmaceutical innovation. IPR, RDP, TPP
58  2015 The scientific rationale for the World Organisation for Animal Health standards and recommendations on avian influenza. OIE, Terrestrial Code
59  2015 Tobacco control and the World Trade Organization: mapping member states' positions after the framework convention on tobacco control. FCTC, GATT, TBT, TRIPS
60  2015 [Essential medicines and the TRIPS Agreement: collision between the right to health and intellectual property rights]. ICESCR, TRIPS
61  2014 Access to medicines and distributive justice: breaching Doha's ethical threshold. NCDs
62  2014 Assessment of the association of health with the liberalisation of trade in services under the World Trade Organisation. GATS, LE, MM, PEH, U5M
63  2014 Compulsory patent licensing and local drug manufacturing capacity in Africa. ---
64  2014 Evolving norms at the intersection of health and trade. ---
65  2014 Exploring risk judgments in a trade dispute using Bayesian networks. BNs, IRA
66  2014 The plights of African resources patenting through the lenses of the World Trade Organisation: an assessment of South Africa's rooibos tea's labyrith journey. ARIPO, ASB, GIs, IK, IPRs, MNCs, PIC, TWSs
67  2013 A study on the transfer of heavy methals released by Chinese commercial products. OECD
68  2013 Animal Disease Import Risk Analysis--a Review of Current Methods and Practice. IRA, OIE, SPS
69  2013 Assessment of the vaccine industry in Iran in context of accession to WTO: a survey study. cGMP, IP, WHO
70  2013 Balancing public health, trade and intellectual monopoly privileges: recent Australian IP legislation and the TPPA. TPPA
71  2013 How do international trade obligations affect policy options for obesity prevention? Lessons from recent developments in trade and tobacco control. ---
72  2013 The challenges of disease risk ascertainment using accessible data sources for numbers of travelers. MDR
73  2013 Trade liberalization and tuberculosis incidence: a longitudinal multi-level analysis in 22 high burden countries between 1990 and 2010. CI, HDI, TB
74  2012 Australia's double standard on Thailand's alcohol warning labels. ---
75  2012 How does the World Trade Organization know? The mobilization and staging of scientific expertise in the GMO trade dispute. SPS
76  2012 How to model a negligible probability under the WTO sanitary and phytosanitary agreement? ---
77  2012 The Food Safety Modernization Act: a barrier to trade? Only if the science says so. ---
78  2012 The new patent regime and disease priorities in India. TRIPS
79  2012 The role of intellectual property rights in treatment access: challenges and solutions. TRIPS
80  2012 Trends in compulsory licensing of pharmaceuticals since the Doha Declaration: a database analysis. CLs, UMICs
81  2012 World Trade Organization activity for health services. GATS
82  2011 Implications of the World Trade Organization in combating non-communicable diseases. WHO
83  2011 Risk analysis and its link with standards of the World Organisation for Animal Health. OIE
84  2011 The spread of pathogens through trade in honey bees and their products (including queen bees and semen): overview and recent developments. ---
85  2010 A one-time-only combination: Emergency medicine exports and the TRIPS agreement under Canada's access to medicines regime. CAMR
86  2010 International cooperation in the solution to trade-related invasive species risks. IHR
87  2010 The role of the World Trade Organization and the 'three sisters' (the World Organisation for Animal Health, the International Plant Protection Convention and the Codex Alimentarius Commission) in the control of invasive alien species and the preservation of biodiversity. CAC, IAS, IPPC, OIE
88  2009 Bridging the divide: global governance of trade and health. GATT
89  2009 Government regulation of pricing and reimbursement of prescription medicines: results of a recent multi-country review. EU
90  2009 The potential impact of the World Trade Organization's general agreement on trade in services on health system reform and regulation in the United States. ---
91  2009 The role of the World Organisation for Animal Health (OIE) to facilitate the international trade in animals and animal products. OIE
92  2009 Trade and health: an agenda for action. ---
93  2008 First test of WTO mechanism for procuring generic medicines under compulsory licence, via Canada's Access to Medicines Regime. ---
94  2008 International jurisprudence on trade and environmental health: one step forward, two steps back? MEAs
95  2008 Trade and health: how World Trade Organization (WTO) law affects alcohol and public health. ---
96  2007 Agricultural science and food policy for consumers and workers: recipes for public health successes or disasters? NGOs
97  2007 British American Tobacco's tactics during China's accession to the World Trade Organization. BAT, EU
98  2007 Risk assessment and surveillance for bovine spongiform encephalopathy. BSE, OIE
99  2007 The right to health. ---
100  2007 Trade policy and public goods. ---